NCT06654193: Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury |
|
|
| Not yet recruiting | 1/2 | 70 | US | Allogeneic HB-adMSCs, Normal Saline | Hope Biosciences, The University of Texas Health Science Center, Houston, University of California, San Francisco, University of Alabama at Birmingham | Acute Kidney Injury | 01/28 | 01/28 | | |